Tetraspanin CD151 Is a Negative Regulator of FcepsilonRI-Mediated Mast Cell Activation

Abdala-Valencia, H.; Bryce, P. J.; Schleimer, R. P.; Wechsler, J. B.; Loffredo, L. F.; Cook-Mills, J. M.; Hsu, C. L.; Berdnikovs, S.

J Immunol. 2015 Jul 3; 195(4):1377-87

Abstract

Mast cells are critical in the pathogenesis of allergic disease due to the release of preformed and newly synthesized mediators, yet the mechanisms controlling mast cell activation are not well understood. Members of the tetraspanin family are recently emerging as modulators of FcepsilonRI-mediated mast cell activation; however, mechanistic understanding of their function is currently lacking. The tetraspanin CD151 is a poorly understood member of this family and is specifically induced on mouse and human mast cells upon FcepsilonRI aggregation but its functional effects are unknown. In this study, we show that CD151 deficiency significantly exacerbates the IgE-mediated late phase inflammation in a murine model of passive cutaneous anaphylaxis. Ex vivo, FcepsilonRI stimulation of bone marrow-derived mast cells from CD151(-/-) mice resulted in significantly enhanced expression of proinflammatory cytokines IL-4, IL-13, and TNF-alpha compared with wild-type controls. However, FcepsilonRI-induced mast cell degranulation was unaffected. At the molecular signaling level, CD151 selectively regulated IgE-induced activation of ERK1/2 and PI3K, associated with cytokine production, but had no effect on the phospholipase Cgamma1 signaling, associated with degranulation. Collectively, our data indicate that CD151 exerts negative regulation over IgE-induced late phase responses and cytokine production in mast cells.

Read More on PubMed